Melanotan II Promotes Skin Tanning CAS:121062-08-6
Melanotan II (MT-II) is a lab-engineered peptide derived from alpha-melanocyte-stimulating hormone (α-MSH), a natural regulator of pigmentation, appetite, and sexual function. Initially developed in the 1980s to combat skin cancer by inducing protective tanning without UV exposure, MT-II gained notoriety for its off-label cosmetic use.
Introduction to Melanotan II
Melanotan II (MT-II) is a lab-engineered peptide derived from alpha-melanocyte-stimulating hormone (α-MSH), a natural regulator of pigmentation, appetite, and sexual function. Initially developed in the 1980s to combat skin cancer by inducing protective tanning without UV exposure, MT-II gained notoriety for its off-label cosmetic use. Unlike traditional tanning methods, MT-II activates melanogenesis through subcutaneous injection or nasal administration, offering a sunless tan. Its multifaceted effects on melanocortin receptors also influence libido and energy balance, making it a compound of both interest and controversy.
Distinctive Features of Melanotan II
1.Synthetic Peptide Structure: MT-II's cyclic heptapeptide structure enhances stability and receptor affinity compared to natural α-MSH, prolonging its activity.
2.Dual Receptor Activation: It binds to MC1R (melanocortin-1 receptor) for tanning and MC4R (melanocortin-4 receptor), affecting appetite and sexual arousal.
3.Rapid Tan Induction: Users report noticeable pigmentation within days, contrasting weeks of sun exposure.
4.Aphrodisiac Properties: Secondary effects include increased erectile function and sexual desire, akin to bremelanotide, an FDA-approved MC4R agonist.
5.UV-Independent Mechanism: Stimulates melanocytes directly, reducing reliance on harmful UV rays for tanning.
Applications Beyond Cosmetic Tanning
●Medical Uses: Investigated for erythropoietic protoporphyria (EPP), a disorder causing severe light sensitivity. MT-II's UV-protective tan alleviates symptoms.
●Libido Enhancement: Early trials explored MT-II for erectile dysfunction, though overshadowed by bremelanotide's development.
●Appetite Suppression: MC4R activation may aid weight loss, though unapproved and under-researched.
Benefits and Risks
Benefits:
●Skin Cancer Mitigation: By promoting melanin, MT-II may lower UV-induced DNA damage.
●Convenience: Avoids prolonged sun exposure, ideal for low-sunlight regions.
●Psychosexual Effects: Enhances confidence through tanning and libido boost.
Risks:
●Hyperpigmentation: Uneven moles or dark spots due to uncontrolled melanocyte activation.
●Nausea/Flushing: Common side effects from MC receptor stimulation.
●Unregulated Market: Lack of FDA oversight raises contamination risks.
Dosage Protocols and Administration
●Initial Loading Phase: 0.5–1 mg daily via subcutaneous injection for 10–14 days to accelerate tanning.
●Maintenance: 1–2 mg weekly, adjusted based on response. Nasal sprays offer non-invasive dosing but with lower bioavailability.
●Titration: Start low (0.25 mg) to gauge tolerance, minimizing side effects.
Cycle Management
●Short-Term Cycles: 4–6 weeks with gradual tapering to sustain melanin levels.
●Breaks: Pause 2–4 weeks to prevent receptor desensitization and assess skin health.
●Combination Use: Stacked with tyrosine supplements to support melanin synthesis.
Pharmacokinetics: Half-Life and Duration
MT-II's plasma half-life is ~2–3 hours, but cumulative effects persist due to prolonged melanocyte stimulation. Tanning results emerge within days and last weeks post-cycle, depending on individual metabolism and dosing consistency.
PTC (Peptide Therapy Considerations)
While PTC isn't a standard acronym, contextualizing it as "Post-Treatment Care" or "Peptide Therapy Compliance" involves:
●Skin Surveillance: Regular checks for new or changing moles, consulting dermatologists.
●Hydration/Nutrition: Counteract appetite loss with balanced diets and electrolytes.
●Side Effect Mitigation: Antiemetics for nausea; sunscreens despite melanin protection.
●Ethical Sourcing: Prioritize reputable labs for peptide purity, avoiding counterfeit products.
Novel Insights and Future Directions
Recent anecdotal reports suggest MT-II's potential in treating rosacea and vitiligo, though evidence remains sparse. Research into its neuroprotective effects via MC4R activation is emerging. However, regulatory hurdles and ethical concerns persist, emphasizing the need for controlled clinical trials.
Clinical Data
|
Trade names |
Melanotan II Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2 Ac-Nle-c[Asp-His-D-Phe-Arg-Trp-Lys]-NH2 |
|
CAS |
121062-08-6 |
|
Molar mass |
1024.180 |
|
MF |
C50H69N15O9 |
|
Purity |
Above 98% |
|
Apprarance |
10mg/vial,Lyophilized powder |
Any needs, please contact us
Email: Jasonraws106@gmail.com
WhatsApp: +86-15572565525
Telegram: +86-19128233885
Conclusion
Melanotan II epitomizes the intersection of cosmetic desire and biochemical innovation. While its tanning efficacy and ancillary benefits attract users, the absence of regulatory approval and long-term safety data necessitates caution. Future advancements may legitimize its medical applications, but current use remains a calculated risk reliant on informed personal choice and vigilant health monitoring.
Hot Tags: Melanotan II Promotes Skin Tanning CAS:121062-08-6, China Melanotan II Promotes Skin Tanning CAS:121062-08-6 manufacturers, suppliers, factory
